Researchers from Trinity College Dublin have developed a new machine-learning technique for classifying key immune cells. It has the potential to one day make major societal impact, writes the university in a press release.
The technique accurately classifies the state of macrophages, which is important because these cells can modify their behavior and act as pro- or anti-inflammatory agents in the immune response. As a result, the work has a suite of implications for research and has the potential to one day make a major societal impact. For example, this new approach could be of use to drug designers looking to create therapies targeting diseases and auto-immune conditions such as diabetes, cancer, and rheumatoid arthritis – all of which are impacted by cellular metabolism and macrophage function.
The landmark research, which used human macrophages in experiments, was led by Michael Monaghan, Associate Professor in Biomedical Engineering at Trinity. “Currently, there are no other methods that employ artificial intelligence-based, machine learning approaches to macrophage classification. A number of different techniques are currently used to classify macrophages, but all of these have significant drawbacks,” Monaghan says. “Our method does not require sample pre-treatment, can be used to follow changes in metabolism non-invasively and in real-time – which opens the door to tracking disease progression and/or physiological response to therapies.”
The full research is published in the eLife journal.
